Ikan Ikan Ikan
Skip to content
IKAN
  • About us
    • Who we are
    • Directors
    • Why zebrafish
    • Partners
  • Technology
  • Services
    • Drug Screening
    • Zebrafish Oncology Platform
    • Personalized Medicine
  • R&D
  • News Room
    • Videos
    • Articles
  • Contact
Menu
  • About us
    • Who we are
    • Directors
    • Why zebrafish
    • Partners
  • Technology
  • Services
    • Drug Screening
    • Zebrafish Oncology Platform
    • Personalized Medicine
  • R&D
  • News Room
    • Videos
    • Articles
  • Contact

Efficacy test in zebrafish of Folfox and Folfiri against HCT116 cells.

  • by globaladmin
  • April 27, 2023April 27, 2023

Zebrafish larvae xenografts as been presented as a wonderful tool that has been widely used in cancer research. This zebrafish avatar model as been developed… Read More »Efficacy test in zebrafish of Folfox and Folfiri against HCT116 cells.

First results in the collaborative R&D project called COLON-HDAC6

  • by globaladmin
  • January 16, 2023March 24, 2023

The COLON-HDAC6 project begins to have its first clarifying results. An MTS test has been carried out with the objective of evaluating the cell proliferation,… Read More »First results in the collaborative R&D project called COLON-HDAC6

why-choose-ikanbiotech

Identification and development of a candidate HDAC6 inhibitor as a treatment against colon cancer (COLON-HDAC6)

  • by globaladmin
  • September 6, 2022March 24, 2023

The COLON-HDAC6 project was born with the purpose of positioning Navarra in the focus of the Leading regions in the development of new antitumor compounds.… Read More »Identification and development of a candidate HDAC6 inhibitor as a treatment against colon cancer (COLON-HDAC6)

New article published on Cancers – “Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study”

  • by globaladmin
  • April 1, 2022April 1, 2022

Zebrafish embryo tumor transplant models are widely utilized in cancer research. Compared with traditional murine models, the small size and transparency of zebrafish embryos combined… Read More »New article published on Cancers – “Systematic Roadmap for Cancer Drug Screening Using Zebrafish Embryo Xenograft Cancer Models: Melanoma Cell Line as a Case Study”

Zebrafish Toxicity Assay as an in vivo model

  • by globaladmin
  • May 2, 2019April 1, 2022

Toxicity assay carry out in zebrafish The controversy surrounding the use of mammals in testing, associated with the problems and limitations inherent in its implementation,… Read More »Zebrafish Toxicity Assay as an in vivo model

Zebrafish: ideal tool for advancement in Biotechnology and Biomedicine

  • by globaladmin
  • March 26, 2019April 1, 2022

Why do we use zebrafish for human solutions? Even if it seems surprising, the reality is that zebrafish and human share high molecular and genetic… Read More »Zebrafish: ideal tool for advancement in Biotechnology and Biomedicine

Zebrafish: speeding Up the Cancer Drug Discovery Process

  • by globaladmin
  • December 12, 2018April 1, 2022

Read full publication on the following link: DOI:10.1158/0008-5472.CAN-18-1029

7th PREDiCT: Tumour Models London

  • by globaladmin
  • October 24, 2018April 1, 2022

London, UK  Wed, Dec 5, 2018 – Thu, Dec 6, 2018

Ikan Biotech has recently obtained the “Crédit Impôt Recherche (CIR)”

  • by globaladmin
  • October 9, 2018April 1, 2022

Ikan Biotech is now certified for “Crédit Impôt Recherche (CIR)” from The French Ministry of Higher Education, Research and Innovation of the Government of France. The CIR… Read More »Ikan Biotech has recently obtained the “Crédit Impôt Recherche (CIR)”

  • 1
  • 2
  • Next »

Contact us

Tell us about your needs

info@ikanbiotech.com

Email

+34 646 574 499

Phone

Mocholi Industrial Park, Plza. CEIN, 5 – A4
IKAN

QUALITY AND R&D POLICY    |    LEGAL NOTICE & PRIVACY POLICY    |    COOKIES POLICY

Linkedin Twitter Youtube
©2022, Ikan Biotech